Document is current
Any future updates will be listed below
-
Authors
Parellada, C. I. https://orcid.org/0000-0002-8536-9274
Reyes, L. F.
Urrego-Reyes, J.
Webster, J. L.
Pungartnik, P. C.
Dos Santos, A C
Rojas, M.
de la Hoz, F.
- License Information
-
More Information
Article History
Received: 4 March 2025
Accepted: 17 June 2025
First Online: 1 September 2025
Declarations
:
: Not applicable. All data used in this study were obtained from publicly accessible, structured databases containing anonymized and aggregated data. These data comply with Resolution 1409 of 2022, issued by the Ministry of Health and Social Protection of Colombia, which permits the secondary use of anonymized data without ethics committee approval for scientific research or public policy formulation.
: Not applicable.
: Cintia Irene Parellada and Paula Cristina Pungartnik are employees of MSD Brazil, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA. Juan Camilo Urrego and Monica Rojas are employees of MSD Colombia, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA; Fernando de la Hoz has declared no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper; Luis Felipe Reyes has received honoraria for lectures, presentations, educational events and support for attending meetings and/or travel from Pfizer, MSD, GSK and JJ; Jessica Webster participated in a paid internship of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA; Angelica Carreira dos Santos is an employee of IQVIA Brazil, which was contracted by Merck & Co., Inc., Rahway, NJ, USA to conduct the study.
